Clever Leaves Launches Project Change Lives, Pledging $25M Worth of Medical Cannabis to U.S. Researchers

Medical, clinical and research organizations may apply for consideration in Project Change Lives

Initial investigational studies underway in collaboration with Biopharmaceutical Research Company

NEW YORK, June 28, 2021 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announces Project Change Lives, a U.S. focused research initiative, whereby the Company has pledged to contribute up to USD$25,000,000 retail value of medical cannabis products to any eligible U.S. organization to help advance scientific research into the potential medical benefits of cannabinoids. By sponsoring Project Change Lives, Clever Leaves is offering to provide a historic amount of pharmaceutical-grade cannabis to leading research institutions in one of the most advanced pharmaceutical markets in the world.

Clever Leaves is looking to supply up to 250,000 bottles of pharmaceutical-grade cannabis oils or approximately 5 tons of medical cannabis flower that will help research institutions develop new therapies. To eliminate an additional impediment to the advancement of scientific knowledge around cannabis, this research material will be provided at no cost to Clever Leaves' research partners. The Company will be partnering with Biopharmaceutical Research Company, a company which holds federal licenses for importing, analyzing and manufacturing controlled substances, as its importer of record. Clever Leaves plans to begin working with U.S. investigators immediately and initiate their efforts with a research study focused on the DNA sequencing of a variety of their cannabis cultivars.